NCT00265005 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants


Sponsors: University of Louisville Genentech	Phases: Phase I
Indications	Acronym:
Catheterization
Age Groups: Child	Gender: Both
Names: Drug: alteplase	Enrollment: 12

Additional information about NCT00265005.